NHS pay rise linked to reform
October 22, 2003Workers throughout the NHS are to receive substantial pay rises in return for undergoing radical ob evaluationreviews over the next …
Novartis files COX-II contender amid class safety concerns
October 22, 2003Novartis has submitted its COX-II inhibitor Prexige to US and European regulators with data from 13,000 clinical trial patients to …
Supplementary prescribing gets go ahead
October 22, 2003Thousands of trained pharmacists and nurses will be able to prescribe drugs for chronic diseases by late 2004, the Government …
Increase marketing RoI or cut back, analysts warn
October 22, 2003Pharmaceutical companies must make their sales and marketing more cost-effective or cut back, according to a new report.Analysts Datamonitor warn …
OGS extends Actelion relationship as Zavesca approved
October 22, 2003Oxford GlycoSciences has announced the EU approval of its first product, Zavesca, and an extension to its co-marketing agreement with …
Red tape could suffocate European clinical trials
October 22, 2003New measures intended to improve the competitiveness of clinical trials in Europe could have the opposite effect, a leading research …
BMS schizophrenia drug wins US approval
October 22, 2003New atypical antipsychotic Abilify has gained FDA approval for the treatment of schizophrenia and is tipped to eventually become a …
National service framework leaders appointed
October 22, 2003Key appointments for the Children's National Service Framework and the Long-term Conditions National Service Framework have been announced.The external working …
Government presses on with MCA merger
October 22, 2003The UK Government is to press ahead with the merger of the Medicines Control Agency and its medical devices counterpart …
Bayer parallel import case reopened
October 22, 2003A landmark legal battle over parallel trade of Bayer's blood pressure treatment Adalat has been re-commenced in the European Court …
New Bextra warnings add to COX-II doubts
October 22, 2003New warnings on the label of second-generation COX-II inhibitor Bextra have added to doubts about the safety of the drug …
Pharmacia man tipped to head Celltech
October 22, 2003Pharmacia's Head of Research and Development, Goran Ando, is tipped to become Celltech's new Chief Executive when its current incumbent …
Pharma marketing’s changing skills set
October 21, 2003Business Services, Sales and Marketing marketing, recruitment, skills
Sales and marketing are undergoing something of a revolution as the pharmaceutical industry reacts to a multitude of challenges. Waning …
New FDA head promises improvements for workforce
October 21, 2003The new FDA Commissioner, Dr Mark McClellan, has pledged that improvements in the working lives of staff will be a …
WTO close to agreeing medicines supply deal
October 21, 2003World Trade Organisation ministers say they are close to striking a deal aimed at improving the provision of medicines to …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
